{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:33:47Z","timestamp":1788305627209,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.siny.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T03:45:37Z","timestamp":1338867937000},"page":"207-215","source":"Crossref","is-referenced-by-count":86,"title":["Neonatal neuroblastoma"],"prefix":"10.1016","volume":"17","author":[{"given":"Jonathan P.H.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Tweddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2012.05.002_bib1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/0959-8049(95)00428-9","article-title":"Childhood cancer in Britain: The National Registry of Childhood Tumours and Incidence Rates 1978\u20131987","volume":"31A","author":"Stiller","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1054\/bjoc.2000.1313","article-title":"Incidence and survival for cancer in children and young adults in the North of England, 1968\u20131995: a report from the Northern Region Young Persons' Malignant Disease Registry","volume":"83","author":"Cotterill","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib3","series-title":"Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995","article-title":"Sympathetic nervous system tumours","author":"Goodman","year":"1999"},{"key":"10.1016\/j.siny.2012.05.002_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.earlhumdev.2010.08.019","article-title":"Neonatal neuroblastoma","volume":"86","author":"Dhir","year":"2010","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.siny.2012.05.002_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0959-8049(00)00058-7","article-title":"Clinical prognostic factors in 1277 patients with neuroblastoma: results of the European Neuroblastoma Study Group survey 1982\u20131992","volume":"36","author":"Cotterill","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib6","series-title":"Neuroblastoma","article-title":"Epidemiology of neuroblastoma","author":"Olshan","year":"2000"},{"key":"10.1016\/j.siny.2012.05.002_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/OGX.0b013e318181a9f0","article-title":"Malignant conditions in children born after assisted reproductive technology","volume":"63","author":"Neelanjana","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.siny.2012.05.002_bib8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2012.05.002_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergen.2011.03.001","article-title":"Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma","volume":"204","author":"Deyell","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.siny.2012.05.002_bib10","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.1999.17.7.2264","article-title":"Molecular biology of neuroblastoma","volume":"17","author":"Maris","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib11","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0959-8049(97)00265-7","article-title":"Molecular genetic analysis of familial neuroblastoma","volume":"33","author":"Maris","year":"1997","journal-title":"Eur J Cancer"},{"issue":"7215","key":"10.1016\/j.siny.2012.05.002_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature07398","article-title":"Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma","volume":"455","author":"Janoueix-Lerosey","year":"2008","journal-title":"Nature"},{"issue":"7215","key":"10.1016\/j.siny.2012.05.002_bib13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.siny.2012.05.002_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/383253","article-title":"Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma","volume":"74","author":"Trochet","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.siny.2012.05.002_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1086\/424530","article-title":"Germline PHOX2B mutation in hereditary neuroblastoma","volume":"75","author":"Mosse","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.siny.2012.05.002_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/428366","article-title":"PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome","volume":"76","author":"Trochet","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.siny.2012.05.002_bib18","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1038\/sj.onc.1208157","article-title":"The Phox2B homeobox gene is mutated in sporadic neuroblastomas","volume":"23","author":"van Limpt","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.siny.2012.05.002_bib19","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.siny.2012.05.002_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.sempedsurg.2005.11.003","article-title":"Perinatal neuroblastoma","volume":"15","author":"Nuchtern","year":"2006","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.siny.2012.05.002_bib21","series-title":"Principles and practice of pediatric oncology","first-page":"895","article-title":"Neuroblastoma","author":"Brodeur","year":"2001"},{"key":"10.1016\/j.siny.2012.05.002_bib22","doi-asserted-by":"crossref","first-page":"F134","DOI":"10.1136\/fn.81.2.F134","article-title":"Neonatal neuroblastoma","volume":"81","author":"Moppett","year":"1999","journal-title":"Archs Dis Childh"},{"key":"10.1016\/j.siny.2012.05.002_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.82.1.51","article-title":"Does Horner's syndrome in infancy require investigation?","volume":"82","author":"George","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.siny.2012.05.002_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors. Recommendations by the International Neuroblastoma Pathology Committee","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/305245a0","article-title":"Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour","volume":"305","author":"Schwab","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.siny.2012.05.002_bib28","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.ejca.2004.07.025","article-title":"MYCN amplification remains prognostically strong 20 years after its \u201cclinical debut\u201d","volume":"40","author":"Cohn","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib29","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMoa052399","article-title":"Chromosome 1p and 11q deletions and outcome in neuroblastoma","volume":"353","author":"Attiyeh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2012.05.002_bib30","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJM199906243402504","article-title":"Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma","volume":"340","author":"Bown","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2012.05.002_bib31","first-page":"203","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nature Rev"},{"key":"10.1016\/j.siny.2012.05.002_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1200\/JCO.2008.16.0630","article-title":"Overall genomic pattern is a predictor of outcome in neuroblastoma","volume":"27","author":"Janoueix-Lerosey","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/1078-0432.CCR-10-0830","article-title":"A\u00a0multilocus technique for risk evaluation of patients with neuroblastoma","volume":"17","author":"Ambros","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.siny.2012.05.002_bib34","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/bjc.2011.472","article-title":"Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable\/disseminated neuroblastoma (a SIOPEN collaborative study)","volume":"105","author":"Schleiermacher","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.2010.29.5196","article-title":"Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1","volume":"29","author":"Rubie","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjc.6604640","article-title":"Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group","volume":"99","author":"De Bernardi","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.siny.2012.05.002_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2008.17.5877","article-title":"Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification","volume":"27","author":"De Bernardi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","article-title":"Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience","volume":"27","author":"Canete","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.siny.2012.05.002_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.canlet.2005.01.053","article-title":"Epidural compression in neuroblastoma: diagnostic and therapeutic aspects","volume":"228","author":"De Bernardi","year":"2005","journal-title":"Cancer Lett"},{"issue":"9619","key":"10.1016\/j.siny.2012.05.002_bib41","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(08)60500-0","article-title":"Screening for neuroblastoma: a resurrected idea?","volume":"371","author":"Maris","year":"2008","journal-title":"Lancet"},{"issue":"9619","key":"10.1016\/j.siny.2012.05.002_bib42","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(08)60523-1","article-title":"Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study","volume":"371","author":"Hiyama","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2012.05.002_bib43","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/1055-9965.EPI-05-0066","article-title":"Increased risk of cancer among\u00a0siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study","volume":"14","author":"Friedman","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.siny.2012.05.002_bib44","series-title":"GeneReviews","article-title":"ALK-related neuroblastoma susceptibility","author":"Johnson","year":"2010"},{"key":"10.1016\/j.siny.2012.05.002_bib45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinbiochem.2008.10.022","article-title":"Reference intervals for urinary catecholamines and metabolites from birth to adulthood","volume":"42","author":"Pussard","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.siny.2012.05.002_bib46","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1200\/JCO.2005.04.0170","article-title":"Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma","volume":"23","author":"Combaret","year":"2005","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X12000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X12000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T04:15:41Z","timestamp":1531628141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X12000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1744165X12000571"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2012.05.002","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}